CD86 regulates myeloma cell survival

Although prognosis for patients with multiple myeloma has improved over the past decade, research toward discovery of new therapeutic avenues is important and could lead to a cure for this plasma cell malignancy. Here we show that blocking the CD28-CD86 pathway via silencing of either CD28 or CD86 l...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Gavile, Catherine M., Barwick, Benjamin G., Newman, Scott, Neri, Paola, Nooka, Ajay K., Lonial, Sagar, Lee, Kelvin P., Boise, Lawrence H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2017
Témata:
Lymphoid Neoplasia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729629/
https://ncbi.nlm.nih.gov/pubmed/29296880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011601
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky